{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:17:33Z","timestamp":1794637053891,"version":"4.9.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008385","name":"Fondazione per la Ricerca sulla Fibrosi Cistica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009880","name":"Regione Lazio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018841","name":"Associazione Italiana Ricerca Alzheimer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018841","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cystic fibrosis (CF) is a rare autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The most common mutation is F508del-CFTR (\u0394F) which leads the encoded ion channel towards misfolding and premature degradation. The disease is characterized by chronic bronchopulmonary obstruction, inflammation and airways colonization by bacteria, which are the major cause of morbidity and mortality. The STING pathway is the main signaling route activated in the presence of both self and pathogen DNA, leading to Type I Interferon (IFN I) production and the innate immune response. In this study, we show for the first time the relationship existing in CF between resistant and recurrent opportunistic infections by <jats:italic>Pseudomonas aeruginosa<\/jats:italic> and the innate immunity impairment. We demonstrate through <jats:italic>ex vivo<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> experiments that the pathway is inadequately activated in \u0394F condition and the use of direct STING agonists, as 2\u2032,3\u2032-cyclic GMP-AMP (2\u2019, 3\u2019 cGAMP), is able to restore the immune response against bacterial colonization. Indeed, upon treatment with the STING pathway agonists, we found a reduction of colony forming units (CFUs) consequent to IFN-\u03b2 enhanced production in <jats:italic>Pseudomonas aeruginosa<\/jats:italic> infected bone marrow derived macrophages and lung tissues from mice affected by Cystic Fibrosis. Importantly, we also verified that the impairment detected in the primary PBMCs obtained from \u0394F patients can be corrected by 2\u2019, 3\u2019 cGAMP. Our work indicates that the cGAS\/STING pathway integrity is crucial in the Cystic Fibrosis response against pathogens and that the restoration of the pathway by 2\u2019, 3\u2019 cGAMP could be exploited as a possible new target for the symptomatic treatment of the disease.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1093212","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T06:34:07Z","timestamp":1677479647000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["The STING\/TBK1\/IRF3\/IFN type I pathway is defective in cystic fibrosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Luca","family":"Occhigrossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Rossin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Rachela","family":"Villella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Speranza","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"D\u2019Eletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Farrace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Nardacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Maria","family":"Fimia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Raia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Piacentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12567-6","article-title":"Cystic fibrosis","volume":"361","author":"Ratjen","year":"2003","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA [published correction appears in science 1989 sep 29;245(4925):1437]","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.75.103004.142532","article-title":"CFTR function and prospects for therapy","volume":"77","author":"Riordan","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2007.05.004","article-title":"Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis [published correction appears in trends pharmacol sci. 2007 sEP;28(9):447","volume":"28","author":"Amaral","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113199990318","article-title":"Rescuing mutant CFTR: a multi-task approach to a better outcomein treating cystic fibrosis","volume":"19","author":"Amaral","year":"2013","journal-title":"Curr Pharm Des"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4161\/15548627.2014.973737","article-title":"Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation","volume":"10","author":"De Stefano","year":"2014","journal-title":"Autophagy"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.04.036","article-title":"Ion channel modulators in cystic fibrosis","volume":"154","author":"Gentzsch","year":"2018","journal-title":"Chest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis.","volume":"373","author":"O'Sullivan","year":"2009","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1997","article-title":"The evolution of cystic fibrosis care","volume":"148","author":"Pittman","year":"2015","journal-title":"Chest"},{"key":"B11","article-title":"Cystic fibrosis and congenital absence of the vas deferens","volume-title":"GeneReviews\u00ae","author":"Ong","year":"2001"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.25248","article-title":"Scientific advisory group and the investigators and coordinators of ESCF. epidemiologic study of cystic fibrosis: 25 years of observational research","volume":"56","author":"Konstan","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.3390\/ijms22126366","article-title":"The multifaceted role of HSF1 in pathophysiology: Focus on its interplay with TG2","volume":"22","author":"Occhigrossi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1152\/physrev.00044.2008","article-title":"Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders","volume":"89","author":"Iismaa","year":"2009","journal-title":"Physiol Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.11.7697","article-title":"Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation","volume":"180","author":"Maiuri","year":"2008","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201745067","article-title":"TG2 regulates the heat-shock response by the post-translational modification of HSF1","volume":"19","author":"Rossin","year":"2018","journal-title":"EMBO Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900993","article-title":"SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation [published correction appears in J immunol","volume":"183","author":"Luciani","year":"2009","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2090","article-title":"Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition","volume":"12","author":"Luciani","year":"2010","journal-title":"Nat Cell Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41419-021-03485-2","article-title":"Transglutaminase type 2 regulates the wnt\/\u03b2-catenin pathway in vertebrates","volume":"12","author":"Rossin","year":"2021","journal-title":"Cell Death Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2001122","article-title":"Transglutaminase 2 regulates innate immunity by modulating the STING\/TBK1\/IRF3 axis","volume":"206","author":"Occhigrossi","year":"2021","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.019","article-title":"Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization","volume":"39","author":"Li","year":"2013","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(99)00262-0","article-title":"Interferon regulatory factors: the next generation","volume":"237","author":"Mamane","year":"1999","journal-title":"Gene"},{"key":"B26","doi-asserted-by":"publisher","first-page":"ra20","DOI":"10.1126\/scisignal.2002521","article-title":"STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway","volume":"5","author":"Tanaka","year":"2012","journal-title":"Sci Signal"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0410216","article-title":"The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-beta-mediated antiviral activity in vitro and in vivo","volume":"89","author":"Shirey","year":"2011","journal-title":"J Leukoc Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2008.03.050","article-title":"Contribution of Ser386 and Ser396 to activation of interferon regulatory factor 3","volume":"379","author":"Chen","year":"2008","journal-title":"J Mol Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1014","article-title":"Transglutaminases: crosslinking enzymes with pleiotropic functions","volume":"4","author":"Lorand","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.476","article-title":"Cysteamine re-establishes the clearance of pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation","volume":"8","author":"Ferrari","year":"2017","journal-title":"Cell Death Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186169","article-title":"Cysteamine-mediated clearance of antibiotic-resistant pathogens in human cystic fibrosis macrophages","volume":"12","author":"Shrestha","year":"2017","journal-title":"PloS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.2.752-759.2000","article-title":"Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets","volume":"68","author":"Haller","year":"2000","journal-title":"Infect Immun"},{"key":"B33","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-16104-4_15","article-title":"Peripheral blood mononuclear cells","volume-title":"The impact of food bioactives on health: in vitro and ex vivo models","author":"Kleiveland","year":"2015"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: chromosome walking and jumping","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2013.02.003","article-title":"Cysteamine: an old drug with new potential","volume":"18","author":"Besouw","year":"2013","journal-title":"Drug Discovery Today"},{"key":"B36","doi-asserted-by":"publisher","first-page":"303\u2013313","DOI":"10.1111\/joim.12714","article-title":"Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection","volume":"283","author":"Palucci","year":"2018","journal-title":"J. Intern. Med."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1006-9","article-title":"Autophagy induction via STING trafficking is a primordial function of the cGAS pathway","volume":"567","author":"Gui","year":"2019","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1661","article-title":"Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs","volume":"10","author":"Li","year":"2014","journal-title":"Nat Chem Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1777624","DOI":"10.1080\/2162402X.2020.1777624","article-title":"Trial watch: STING agonists in cancer therapy","volume":"9","author":"Le Naour","year":"2020","journal-title":"Oncoimmunology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1093212\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T06:34:12Z","timestamp":1677479652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1093212\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2023.1093212"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1093212","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2023.1093212.s001","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"article-number":"1093212"}}